Daniela Marino: what I wish I knew before starting CUTISS
30-07-2024 – Venturelab recently spoke to our former Project Leader of denovoSkin who is now Co-Founder and CEO of CUTISS AG. Learn more about her experience with a biotech startup and what she would do differently.
Founded in 2017, CUTISS is a leading biotech company dedicated to transforming patients' lives with skin defects by growing human skin in the lab. Then known as denovoSkin, the project joined the Wyss Zurich accelerator in 2016 and incorporated in 2017, then successfully phasing out in February 2022.
CUTISS was listed in the TOP 100 Swiss Startups from 2017 to 2022. In 2018, Daniela Marino participated in the Venture Leaders Life Sciences program, pitching to investors with the Swiss National Startup Team in Boston. The biotech startup has also been recognized as one of the TOP 100 Scale-ups in 2023.
To date, CUTISS has raised CHF 92 million in capital. We talked with Daniela Marino who is also a mother, and figured out a way to reconcile family and startup life.
